The Net Margin of OncoTherapy Science Inc (4564.T) is -211.13%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
| Date | Value |
|---|---|
| 2024-03-31 | -211.13% |
| 2023-03-31 | -98.57% |
| 2022-03-31 | -222.90% |
| 2021-03-31 | -469.70% |
| 2020-03-31 | -707.92% |
| 2019-03-31 | -1046.01% |
| 2018-03-31 | -1349.62% |
| 2017-03-31 | -1047.23% |
| 2016-03-31 | -1044.88% |
| 2015-03-31 | -173.37% |